Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) Net Margin (2016 - 2020)

Historic Net Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 5226.32%.

  • Syndax Pharmaceuticals' Net Margin fell 14881600.0% to 5226.32% in Q4 2020 from the same period last year, while for Sep 2021 it was 5226.32%, marking a year-over-year decrease of 8909200.0%. This contributed to the annual value of 1346.11% for FY2024, which is N/A changed from last year.
  • Syndax Pharmaceuticals' Net Margin amounted to 5226.32% in Q4 2020, which was down 14881600.0% from 5238.26% recorded in Q3 2020.
  • Over the past 5 years, Syndax Pharmaceuticals' Net Margin peaked at 1594.89% during Q4 2017, and registered a low of 5238.26% during Q3 2020.
  • In the last 5 years, Syndax Pharmaceuticals' Net Margin had a median value of 4309.0% in 2017 and averaged 4162.45%.
  • In the last 5 years, Syndax Pharmaceuticals' Net Margin skyrocketed by 317537900bps in 2016 and then crashed by -34927400bps in 2018.
  • Syndax Pharmaceuticals' Net Margin (Quarter) stood at 3564.92% in 2016, then surged by 55bps to 1594.89% in 2017, then crashed by -219bps to 5087.63% in 2018, then increased by 27bps to 3738.16% in 2019, then tumbled by -40bps to 5226.32% in 2020.
  • Its Net Margin was 5226.32% in Q4 2020, compared to 5238.26% in Q3 2020 and 4382.59% in Q2 2020.